Study to investigate safety, tolerability and PK of SAR441566 including food effect and DDI in healthy participants and safety and tolerability including clinical response after 4-week in participants with mild to moderate psoriasis

Trial Identifier:	TDR16920
Sponsor:	Sanofi
Start Date:	August 2021
Study Completion Date:	February 2022
Condition:	Rheumatoid Arthritis; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Germany

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.